The Department of Justice and a manufacturer of the widely used abortion drug mifepristone asked the Supreme Court on Friday to reverse a lower court ruling that if allowed to go into effect would restrict access to the drug . The filings mean that the justices could finally decide the longrunning abortionrelated dispute next summer putting the court in the middle of US presidential and congressional politics . The case is the most important abortion related dispute to come before the justices since the landmark decision in that overturned Roe v. Wade and triggered conservative states across the country to either ban or severely restrict the procedure . Medication abortion makes up the majority of abortions obtained in the United States . The new case could make it harder for women to access abortion even in states that still allow it . If the appeals court decision is ultimately allowed to stand the window to obtain the drug will narrow to weeks from weeks although some prescribers might prescribe offlabel beyond weeks. Dosages will change from mg to mg which the FDA says is higher than necessary which the drug would be changed from mg which they say is high than necessary . It would not be available by mail and the administration of the medication abortion will have to be done by a doctor instead of others authorized to prescribe drugs under state law including a midwife physician assistant or nurse practitioner. It would have to go by a midwives or midwives . If it is ultimately allow to stand, it would be limited to weeks. It will not be allowed to be available to . The FDA says the FDA say is higher to mg. which the . FDA says it would not have to change frommg to mg but the FDA said is higher. It is not available to provide the drug. The FDA say it is higher . Dosages .
DOJ and Mifepristone maker ask Supreme Court to make ultimate decision on abortion
